| Tardive Dyskinesia |
1 |
0.09 |
| Antipsychotics |
0 |
0.99 |
| Atypical Antipsychotics |
0 |
0.98 |
| Schizophrenia |
0 |
0.62 |
| Dopamine |
0 |
0.3 |
| Caregiver |
0 |
0.24 |
| Impairment |
0 |
0.18 |
| Chorea |
0 |
0.12 |
| Metabolism |
0 |
0.12 |
| Molecular Medicine |
0 |
0.12 |
| Mood Disorders |
0 |
0.12 |
| Vitamin |
0 |
0.12 |
| Extrapyramidal Symptoms |
0 |
0.1 |
| Rubella |
0 |
0.1 |
| Intellectual Disability |
0 |
0.08 |
| Cardiovascular Risk Management |
0 |
0.07 |
| Depression |
0 |
0.07 |
| Herpes Simplex |
0 |
0.07 |
| Huntington Disease |
0 |
0.07 |
| Hyponatremia |
0 |
0.07 |
| Lipids Management |
0 |
0.07 |
| Parkinson Disease |
0 |
0.07 |
| Patient Safety |
0 |
0.07 |
| Pediatric Respiratory Infections |
0 |
0.07 |
| Abuse |
0 |
0.06 |
| Adverse Effects |
0 |
0.06 |
| Board Certification |
0 |
0.06 |
| Brain |
0 |
0.06 |
| Buccal Region |
0 |
0.06 |
| Clinical Guidelines |
0 |
0.06 |
| Disability |
0 |
0.06 |
| Dyskinesia |
0 |
0.06 |
| Dystonia |
0 |
0.06 |
| Exercise |
0 |
0.06 |
| Fish Oil |
0 |
0.06 |
| Grant |
0 |
0.06 |
| Hand |
0 |
0.06 |
| Hypernatremia |
0 |
0.06 |
| Hyperparathyroidism |
0 |
0.06 |
| Hypoparathyroidism |
0 |
0.06 |
| Isolation |
0 |
0.06 |
| Measles |
0 |
0.06 |
| Meta-Analysis |
0 |
0.06 |
| Mumps |
0 |
0.06 |
| Myoclonus |
0 |
0.06 |
| Negative Symptoms of Schizophrenia |
0 |
0.06 |
| Neurotransmitters |
0 |
0.06 |
| Nevada |
0 |
0.06 |
| New York |
0 |
0.06 |
| Orphan Drugs |
0 |
0.06 |
| Parkinsonian |
0 |
0.06 |
| Pedal |
0 |
0.06 |
| Plasma |
0 |
0.06 |
| Psychopharmacology |
0 |
0.06 |
| Psychosocial |
0 |
0.06 |
| Receptors |
0 |
0.06 |
| Stigma |
0 |
0.06 |
| Tremor |
0 |
0.06 |
| Trunk |
0 |
0.06 |
| Uremia |
0 |
0.06 |
| Varicella-Zoster Virus |
0 |
0.06 |